ID2 and central nervous system cancer: In gliomas, it has been reported that DYRK1A may destabilize HIF2-alpha in hypoxic conditions by phosphorylating thr27 of ID2, leading to reduced self-renewal of glioma stem cells, the inhibition of tumor growth, and more favorable outcomes for patients with glioblastoma [142].